Korean J Urol Oncol.
2016 Apr;14(1):10-17. 10.0000/kjuo.2016.14.1.10.
Quality of Life in Prostate Cancer Patient Undergoing Androgen Deprivation Therapy
- Affiliations
-
- 1Department of Urology, Chonnam National University Medical School, Gwangju, Korea. sydad@hanmail.net
- KMID: 2411174
- DOI: http://doi.org/10.0000/kjuo.2016.14.1.10
Abstract
- Androgen deprivation therapy (ADT) has been one of the standard protocol for treating prostate cancer. The role for hormonal treatment initially was restricted to men with metastatic and inoperable, locally advanced disease. Now it has been extended to neoadjuvant or adjuvant therapy for surgery and radiotherapy, for biochemical relapse after surgery or radiation, and even as primary therapy for non-metastatic disease. Although ADT can improve survival, it can also cause significant morbidity and a decrement in quality of life (QOL). In this article, we discuss QOL problem caused by ADT and suggest for mitigating harm of ADT.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chemotherapy With Androgen Deprivation for Hormone-Naïve Prostate Cancer
- Erratum: Quality of Life in Prostate Cancer Patient Undergoing Androgen Deprivation Therapy
- Improved Quality of Life (QOL) During the Off-treatment Intervals of the Intermittent Androgen Deprivation (IAD) in the Prostate Cancer Patients
- Comparison of Symptoms, Depression, Intimacy, and Quality of Life According to Treatment Duration in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy
- Current Concepts in Androgen Deprivation Therapy
